Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2023-08-10 Earnings Release
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Trading update for the year ended 30 June 2023
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is an announcement made on '10 August 2023' providing a 'Trading update for the year ended 30 June 2023'. This is a preliminary release of financial performance highlights for a period, not the full annual report (10-K) or a comprehensive interim report (IR). It contains key financial figures (Revenue, Operating Loss) and outlook information, which aligns perfectly with the definition of an Earnings Release (ER). The presence of the RNS footer confirms it is a regulatory announcement, but 'ER' is more specific than the general 'RNS' fallback. FY 2023
2023-08-10 English
Result of General Meeting
AGM Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 7738H) on July 31, 2023. The primary subject is the 'Result of General Meeting'. It explicitly details that all resolutions were passed at the General Meeting held to approve the Company's annual report and accounts for the year ended June 30, 2022. Crucially, it presents the poll results for the resolutions, including the resolution to receive the Directors' report and financial statements, and the resolution to approve the Directors' remuneration report. Since this document reports the official results of a shareholder vote at a general meeting, it directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'. Although it mentions the Annual Report (2022 Accounts) and Remuneration Report, the document itself is the *result* announcement, not the reports themselves. Therefore, the classification is DVA.
2023-07-31 English
Appointment of Chief Financial Officer
Board/Management Information Classification · 98% confidence The document is a formal announcement dated July 10, 2023, originating from 'RNS Number : 5339F' and explicitly states it is provided by RNS, the news service of the London Stock Exchange. The content details the 'Appointment of Chief Financial Officer' (CFO), including the promotion of Shaun Furlong and the departure of the interim CFO. This type of announcement regarding changes in senior management fits the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the core subject matter is management change, making MANG the most specific classification over the general RNS fallback.
2023-07-10 English
Group of companies' accounts made up to 2022-06-30
Regulatory Filings
2023-07-04 English
Interim Results and Lifting Suspension in Trading
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Results for the six months ended 31 December 2022' and contains comprehensive financial statements, including a consolidated income statement, balance sheet, and statement of changes in equity. It provides a detailed financial review and management commentary for a period shorter than a full fiscal year. It is not merely an announcement or a certification, but the actual interim report itself, fitting the definition of an Interim / Quarterly Report (IR). H1 2023
2023-06-19 English
Publication of Annual Report and Accounts 2022
Report Publication Announcement Classification · 100% confidence The document is an RNS announcement dated June 19, 2023, titled "Publication of Annual Report and Accounts 2022". It explicitly states that the company has published its Annual Report and Accounts for the year ended June 30, 2022, and provides a link to view/download it. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement whose primary purpose is to state that a full report has been published, rather than containing the full report content itself, should be classified as a Report Publication Announcement (RPA). Although the content discusses the 2022 Accounts (which would normally suggest 10-K or AR), the document's structure and explicit statement of 'Publication of...' strongly indicate it is the announcement of the report's release, not the report itself. Therefore, RPA is the most appropriate classification.
2023-06-19 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.